8-K Announcements
6Material company update
Apr 29, 2026·SEC
Material company update
Feb 12, 2026·SEC
Material company update
Jan 5, 2026·SEC
Sabra Health Care REIT, Inc.(SBRA)Earnings, Financials & Key Ratios
SBRA•NASDAQ•REIT / Real Estate
28.3× P/E·Price updated Jun 19, 2026
AboutAs of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing - Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.Show more
- Revenue$775M+10.2%
- FFO$343M+15.6%
- FFO/Share1.40+11.6%
- FFO Payout84.5%-10.6%
- FFO per Share1.40+11.6%
- NOI Margin65%-4.0%
- FFO Margin44.23%+5.0%
- ROE5.59%+22.3%
- ROA2.88%+21.6%
SBRA Key Insights
Sabra Health Care REIT, Inc. (SBRA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓FFO growing 13.5% TTM
- ✓High NOI margin of 65.0%
✗Weaknesses
- ✗Weak 3Y average ROE of 3.5%
- ✗Dividend payout exceeds 100% of earnings
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when SBRA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
SBRA Price & Volume
Sabra Health Care REIT, Inc. (SBRA) stock price & volume — 10-year historical chart
Loading chart...
SBRA Growth Metrics
Sabra Health Care REIT, Inc. (SBRA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years12.48%
5 Years5.29%
3 Years7.43%
TTM12.89%
Profit CAGR
10 Years6.96%
5 Years2.37%
3 Years-
TTM10.96%
EPS CAGR
10 Years-5.36%
5 Years-0.91%
3 Years-
TTM7.19%
Return on Capital
10 Years5.2%
5 Years4.43%
3 Years4.79%
Last Year5.16%
SBRA Recent Earnings
Sabra Health Care REIT, Inc. (SBRA) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 11/12 qtrs (92%)
Q2 2026Latest
Apr 29, 2026Metric
Actual
Est
EPS
$0.39+134.0%
$0.17
Rev
$222M+6.0%
$209M
Q1 2026
Feb 12, 2026Metric
Actual
Est
EPS
$0.38+123.5%
$0.17
Rev
$212M+7.0%
$198M
Q4 2025
Nov 5, 2025Metric
Actual
Est
EPS
$0.38+0.0%
$0.38
Rev
$190M-5.9%
$202M
Q3 2025
Aug 4, 2025Metric
Actual
Est
EPS
$0.38+2.7%
$0.37
Rev
$189M+0.9%
$187M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 29, 2026 | $0.39vs $0.17+134.0% | $222Mvs $209M+6.0% |
| Q1 2026 | Feb 12, 2026 | $0.38vs $0.17+123.5% | $212Mvs $198M+7.0% |
| Q4 2025 | Nov 5, 2025 | $0.38vs $0.38+0.0% | $190Mvs $202M-5.9% |
| Q3 2025 | Aug 4, 2025 | $0.38vs $0.37+2.7% | $189Mvs $187M+0.9% |
Based on last 12 quarters of dataView full earnings history →
SBRA Peer Comparison
Sabra Health Care REIT, Inc. (SBRA) competitors in Senior housing and skilled nursing — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 WELL | 144.78B | 206.65 | 148.67 | 35.82% | 12.31% | 3.49% | 0.49 | |
 VTR | 38.8B | 81.61 | 151.13 | 18.47% | 4.25% | 2.08% | 1.05 | |
 OHI | 13.26B | 44.53 | 22.95 | 13.95% | 51.02% | 11.85% | 0.78 | |
 LTC | 1.86B | 36.37 | 14.43 | 25.26% | 39.08% | 10.9% | 0.73 | |
 CTRE | 8.76B | 37.06 | 23.61 | 108.79% | 71.55% | 8.63% | 0.22 | |
 NHI | 3.43B | 70.82 | 23.45 | 12.93% | 36.76% | 9.78% | 0.76 | |
 HR | 6.9B | 19.79 | -27.87 | -6.92% | -17.51% | -4.28% | 0.89 | |
 DOC | 13.6B | 19.56 | 195.60 | 4.52% | 7.73% | 2.6% | 1.26 |
Compare SBRA vs Peers
Sabra Health Care REIT, Inc. (SBRA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
SBRA Income Statement
Sabra Health Care REIT, Inc. (SBRA) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 405.65M | 623.41M | 668.18M | 598.57M | 569.54M | 624.81M | 647.51M | 703.24M | 774.63M | 812.84M |
Revenue Growth % | 55.7% | 53.68% | 7.18% | -10.42% | -4.85% | 9.7% | 3.63% | 8.61% | 10.15% | 12.89% |
Property Operating Expenses | 17.86M | 49.55M | 109.71M | 131.55M | 141.2M | 162.61M | 195.25M | 227.09M | 271.11M | 296.81M |
Net Operating Income (NOI) | 387.79M▲ 0% | 573.86M▲ 48.0% | 558.48M▼ 2.7% | 467.02M▼ 16.4% | 428.34M▼ 8.3% | 462.2M▲ 7.9% | 452.27M▼ 2.1% | 476.15M▲ 5.3% | 503.53M▲ 5.8% | 516.03M▲ 0% |
NOI Margin % | 95.6% | 92.05% | 83.58% | 78.02% | 75.21% | 73.97% | 69.85% | 67.71% | 65% | 63.48% |
Operating Expenses | 163.4M | 266.91M | 30.89M | 467.02M | 217.59M | 227.36M | 230.56M | 219.12M | 239.66M | 280.47M |
G&A Expenses | 32.4M | 36.46M | 30.89M | 32.76M | 34.67M | 39.57M | 47.47M | 50.07M | 53.71M | 55.84M |
EBITDA | 387.82M | 613.14M | 708.63M | 416.29M | 389.74M | 422.62M | 404.8M | 426.65M | 450.86M | 432.19M |
EBITDA Margin % | 95.6% | 98.35% | 106.05% | 69.55% | 68.43% | 67.64% | 62.52% | 60.67% | 58.2% | 53.17% |
Depreciation & Amortization | 163.43M | 306.19M | 181.04M | 176.74M | 178.99M | 187.78M | 183.09M | 169.62M | 187M | 196.63M |
D&A / Revenue % | 40.29% | 49.11% | 27.09% | 29.53% | 31.43% | 30.05% | 28.28% | 24.12% | 24.14% | 24.19% |
Operating Income | 224.39M▲ 0% | 306.95M▲ 36.8% | 527.59M▲ 71.9% | 0▼ 100.0% | 210.75M▲ 0% | 234.84M▲ 11.4% | 221.71M▼ 5.6% | 257.03M▲ 15.9% | 263.87M▲ 2.7% | 235.56M▲ 0% |
Operating Margin % | 55.32% | 49.24% | 78.96% | 0% | 37% | 37.59% | 34.24% | 36.55% | 34.06% | 28.98% |
Interest Expense | 88.44M | 147.11M | 126.61M | 100.42M | 98.63M | 105.47M | 112.96M | 115.27M | 112.49M | 4M |
Interest Coverage | 2.80x | 2.92x | 2.73x | 2.39x | -0.13x | 0.28x | 1.14x | 2.11x | 2.40x | - |
Non-Operating Income | -14.93M | -122.92M | 181.55M | -239.55M | 223.53M | 205.73M | 92.99M | 14.04M | -5.97M | -5.94M |
Pretax Income | 159.02M▲ 0% | 282.13M▲ 77.4% | 72.42M▼ 74.3% | 139.13M▲ 92.1% | -111.41M▼ 180.1% | -76.36M▲ 31.5% | 15.76M▲ 120.6% | 127.72M▲ 710.5% | 157.35M▲ 23.2% | 156.06M▲ 0% |
Pretax Margin % | 39.2% | 45.26% | 10.84% | 23.24% | -19.56% | -12.22% | 2.43% | 18.16% | 20.31% | 19.2% |
Income Tax | 651K | 3.01M | 3.4M | 710K | 1.84M | 1.24M | 2M | 1M | 1.84M | 1.95M |
Effective Tax Rate % | 0.41% | 1.07% | 4.7% | 0.51% | -1.66% | -1.63% | 12.7% | 0.79% | 1.17% | 1.25% |
Net Income | 158.38M▲ 0% | 279.08M▲ 76.2% | 69M▼ 75.3% | 138.42M▲ 100.6% | -113.26M▼ 181.8% | -77.61M▲ 31.5% | 13.76M▲ 117.7% | 126.71M▲ 821.1% | 155.61M▲ 22.8% | 156.19M▲ 0% |
Net Margin % | 39.04% | 44.77% | 10.33% | 23.12% | -19.89% | -12.42% | 2.12% | 18.02% | 20.09% | 19.21% |
Net Income Growth % | 125.37% | 76.21% | -75.28% | 100.62% | -181.82% | 31.48% | 117.73% | 821.14% | 22.81% | 10.96% |
Funds From Operations (FFO) | 321.81M▲ 0% | 585.27M▲ 81.9% | 250.04M▼ 57.3% | 315.15M▲ 26.0% | 65.73M▼ 79.1% | 110.18M▲ 67.6% | 196.84M▲ 78.7% | 296.33M▲ 50.5% | 342.61M▲ 15.6% | 352.82M▲ 0% |
FFO Margin % | 79.33% | 93.88% | 37.42% | 52.65% | 11.54% | 17.63% | 30.4% | 42.14% | 44.23% | 43.41% |
FFO Growth % | 97.15% | 81.87% | -57.28% | 26.04% | -79.14% | 67.61% | 78.66% | 50.54% | 15.61% | 64.73% |
FFO per Share | 3.04 | 3.27 | 1.33 | 1.52 | 0.30 | 0.48 | 0.85 | 1.26 | 1.40 | 1.38 |
FFO Payout Ratio % | 56.58% | 55.57% | 134.15% | 88.31% | 399.97% | 251.56% | 140.95% | 94.54% | 84.5% | 61.82% |
EPS (Diluted) | 1.40▲ 0% | 1.56▲ 11.4% | 0.37▼ 76.3% | 0.67▲ 81.1% | -0.52▼ 177.6% | -0.34▲ 34.6% | 0.06▲ 117.4% | 0.54▲ 813.7% | 0.64▲ 18.5% | 0.61▲ 0% |
EPS Growth % | 52.17% | 11.43% | -76.28% | 81.08% | -177.61% | 34.62% | 117.38% | 813.71% | 18.52% | 7.19% |
EPS (Basic) | 1.40 | 1.57 | 0.37 | 0.67 | -0.52 | -0.34 | 0.06 | 0.54 | 0.64 | - |
Diluted Shares Outstanding | 105.84M | 178.72M | 188.13M | 207.25M | 219.07M | 230.95M | 232.79M | 236.05M | 244.5M | 255.97M |
SBRA Balance Sheet
Sabra Health Care REIT, Inc. (SBRA) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Assets | 7.03B | 6.67B | 6.07B | 5.99B | 5.97B | 5.75B | 5.39B | 5.3B | 5.49B | 5.59B |
Asset Growth % | 210.35% | -5.22% | -8.94% | -1.38% | -0.32% | -3.67% | -6.29% | -1.53% | 3.58% | 13.69% |
Real Estate & Other Assets | 5.99B | 5.85B | 5.34B | 5.29B | 5.5B | 5.32B | 4.98B | 4.9B | 5.06B | 0 |
PP&E (Net) | 5.99B | 5.85B | 9.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investment Securities | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 |
Total Current Assets | 822.24M | 296.28M | 262.66M | 285.07M | 253.99M | 201.84M | 180.53M | 198.09M | 189.43M | 264.62M |
Cash & Equivalents | 518.63M | 50.23M | 39.1M | 59.08M | 112M | 49.31M | 41.28M | 60.47M | 71.54M | 116.53M |
Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
Other Current Assets | 68.82M | 9.43M | 10.05M | 6.45M | 3.89M | 4.62M | 5.43M | 5.87M | 6.6M | 0 |
Intangible Assets | 167.12M | 131.1M | 0 | 0 | 54.06M | 40.13M | 30.9M | 27.46M | 65.32M | 67.41M |
Total Liabilities | 3.6B | 3.41B | 2.58B | 2.58B | 2.59B | 2.69B | 2.58B | 2.56B | 2.67B | 2.8B |
Total Debt | 3.39B | 3.23B | 2.48B | 2.43B | 2.44B | 2.55B | 2.45B | 2.44B | 2.55B | 1.26B |
Net Debt | 2.88B | 3.18B | 2.43B | 2.36B | 2.33B | 2.5B | 2.41B | 2.38B | 2.48B | 1.14B |
Long-Term Debt | 3.39B | 3.23B | 2.4B | 2.35B | 2.39B | 2.31B | 2.32B | 2.31B | 2.31B | 0 |
Short-Term Borrowings | 0 | 3.42M | 3.57M | 18.42M | 0 | 196.98M | 94.43M | 106.55M | 217.58M | 1.26B |
Capital Lease Obligations | 98.02M | 83.73M | 79.75M | 57.73M | 49.71M | 42.24M | 32.53M | 26.85M | 21.38M | 67.76M |
Total Current Liabilities | 102.52M | 94.83M | 0 | 0 | 142.99M | 339.24M | 231.41M | 224.45M | 336.91M | 1.26B |
Accounts Payable | 102.52M | 94.83M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue | 3.6B | 3.41B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Liabilities | 0 | -1.29B | -2.48B | -2.41B | 0 | 0 | 0 | 0 | 0 | 1.55B |
Total Equity | 3.44B▲ 0% | 3.25B▼ 5.3% | 3.49B▲ 7.2% | 3.41B▼ 2.3% | 3.38B▼ 0.9% | 3.06B▼ 9.6% | 2.8B▼ 8.3% | 2.74B▼ 2.2% | 2.82B▲ 3.0% | 2.79B▲ 0% |
Equity Growth % | 238.44% | -5.31% | 7.18% | -2.27% | -0.87% | -9.56% | -8.31% | -2.19% | 3.01% | 7.34% |
Shareholders Equity | 3.43B | 3.25B | 3.49B | 3.41B | 3.38B | 3.06B | 2.8B | 2.74B | 2.82B | 2.79B |
Minority Interest | 4.44M | 4.33M | 0 | 0 | 0 | 0 | 0 | 0 | 1.95M | 1.88M |
Common Stock | 1.78M | 1.78M | 2.05M | 2.11M | 2.3M | 2.31M | 2.31M | 2.38M | 2.52M | 2.52M |
Additional Paid-in Capital | 3.64B | 3.51B | 4.07B | 4.16B | 4.48B | 4.49B | 4.49B | 4.59B | 4.84B | 0 |
Retained Earnings | -217.24M | -271.6M | -573.28M | -716.2M | -1.1B | -1.45B | -1.72B | -1.87B | -2.01B | 0 |
Preferred Stock | 58K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Return on Assets (ROA) | 3.41% | 4.07% | 1.08% | 2.3% | -1.9% | -1.32% | 0.25% | 2.37% | 2.88% | 2.84% |
Return on Equity (ROE) | 7.11% | 8.34% | 2.05% | 4.01% | -3.34% | -2.41% | 0.47% | 4.57% | 5.59% | 5.6% |
Debt / Assets | 48.27% | 48.49% | 40.89% | 40.6% | 40.96% | 44.35% | 45.42% | 46.09% | 46.42% | 22.47% |
Debt / Equity | 0.99x | 0.99x | 0.71x | 0.71x | 0.72x | 0.83x | 0.87x | 0.89x | 0.90x | 0.45x |
Net Debt / EBITDA | 7.42x | 5.19x | 3.43x | 5.68x | 5.98x | 5.91x | 5.94x | 5.59x | 5.50x | 2.64x |
Book Value per Share | 32.48 | 18.21 | 18.54 | 16.45 | 15.43 | 13.23 | 12.04 | 11.61 | 11.55 | 10.89 |
SBRA Cash Flow Statement
Sabra Health Care REIT, Inc. (SBRA) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 133.49M | 358.54M | 372.48M | 354.85M | 356.39M | 315.73M | 300.57M | 310.54M | 348.61M | 366.71M |
Operating CF Growth % | -24.47% | 168.6% | 3.89% | -4.73% | 0.43% | -11.41% | -4.8% | 3.32% | 12.26% | 35.28% |
Operating CF / Revenue % | 32.91% | 57.51% | 55.74% | 59.28% | 62.57% | 50.53% | 46.42% | 44.16% | 45% | 45.11% |
Net Income | 158.37M | 279.12M | 69.02M | 138.42M | -113.26M | -77.61M | 13.76M | 126.71M | 155.51M | 156.19M |
Depreciation & Amortization | 112.97M | 199.08M | 181.55M | 176.74M | 178.99M | 187.78M | 183.09M | 169.62M | 187M | 196.51M |
Stock-Based Compensation | 8.36M | 7.65M | 9.82M | 7.91M | 7.91M | 7.45M | 7.92M | 8.99M | 11.36M | 11.75M |
Other Non-Cash Items | -22.86M | -36.31M | -22.16M | 1.61M | 32.2M | 217.8M | 98.55M | 27.77M | 4.6M | 4.68M |
Working Capital Changes | -90.31M | -18.5M | -23.51M | -2.74M | 22.7M | -19.69M | -2.73M | -22.55M | -9.85M | -2.33M |
Cash from Investing | -240.07M | -258.49M | 262.84M | -136.45M | -336.2M | -216.25M | 103.13M | -109M | -377.96M | -466.61M |
Acquisitions (Net) | 77.86M | -354.46M | 0 | -16.65M | -7.77M | -142.91M | -5.24M | 0 | 0 | 1.98M |
Purchase of Investments | -2.75M | -5.31M | -89.65M | -20.07M | -9.06M | -8.02M | -11.02M | 0 | 0 | 0 |
Sale of Investments | 3.75M | 6.87M | 5.08M | 3.42M | 1.29M | 5.38M | 0 | 0 | 0 | -1.37M |
Other Investing | 15.19M | 1.06M | 347.42M | 2.44M | -287.05M | -70.69M | 119.39M | -109M | -377.96M | -467.21M |
Cash from Financing | 598.82M | -629.34M | -646.18M | -202.11M | 30.14M | -161.71M | -410.3M | -181.56M | 40.76M | 194.1M |
Dividends Paid | -182.09M | -325.22M | -335.44M | -278.3M | -262.92M | -277.16M | -277.45M | -280.15M | -289.5M | -293.78M |
Common Dividends | -182.09M | -325.22M | -335.44M | -278.3M | -262.92M | -277.16M | -277.45M | -280.15M | -289.5M | -218.12M |
Debt Issuance (Net) | 1000K | -1000K | -1000K | -1000K | 1000K | 1000K | -1000K | 1000K | 1000K | 1000K |
Share Repurchases | 0 | -143.75M | 0 | 0 | 0 | -4.81M | -2.68M | 0 | 0 | 0 |
Other Financing | -15.75M | -2.54M | -10.82M | -830K | -39.51M | -2.52M | -36.04M | -94K | -5.24M | 122.59M |
Net Change in Cash | 492.97M▲ 0% | -527.79M▼ 207.1% | -10.52M▲ 98.0% | 16.38M▲ 255.8% | 50.36M▲ 207.5% | -61.95M▼ 223.0% | -7.21M▲ 88.4% | 19.62M▲ 372.0% | 11.8M▼ 39.9% | 94.55M▲ 0% |
Exchange Rate Effect | 738K | -539K | 346K | 88K | 29K | 268K | -614K | -359K | 391K | 410K |
Cash at Beginning | 25.66M | 587.45M | 59.66M | 49.14M | 65.52M | 115.89M | 53.93M | 46.72M | 66.34M | 78.14M |
Cash at End | 518.63M | 59.66M | 49.14M | 65.52M | 115.89M | 53.93M | 46.72M | 66.34M | 78.14M | 123.45M |
Free Cash Flow | -200.64M▲ 0% | 451.89M▲ 325.2% | 372.48M▼ 17.6% | 249.26M▼ 33.1% | 322.78M▲ 29.5% | 315.73M▼ 2.2% | 300.57M▼ 4.8% | 310.54M▲ 3.3% | 348.61M▲ 12.3% | 366.71M▲ 0% |
FCF Growth % | -213.52% | 325.22% | -17.57% | -33.08% | 29.5% | -2.18% | -4.8% | 3.32% | 12.26% | 8.49% |
FCF / Revenue % | -49.46% | 72.49% | 55.74% | 41.64% | 56.67% | 50.53% | 46.42% | 44.16% | 45% | 45.11% |
SBRA Key Ratios
Sabra Health Care REIT, Inc. (SBRA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
FFO per Share | 3.04 | 3.27 | 1.33 | 1.52 | 0.3 | 0.48 | 0.85 | 1.26 | 1.4 | 1.38 |
FFO Payout Ratio | 56.58% | 55.57% | 134.15% | 88.31% | 399.97% | 251.56% | 140.95% | 94.54% | 84.5% | 61.82% |
NOI Margin | 95.6% | 92.05% | 83.58% | 78.02% | 75.21% | 73.97% | 69.85% | 67.71% | 65% | 63.48% |
Net Debt / EBITDA | 7.42x | 5.19x | 3.43x | 5.68x | 5.98x | 5.91x | 5.94x | 5.59x | 5.50x | 2.64x |
Debt / Assets | 48.27% | 48.49% | 40.89% | 40.6% | 40.96% | 44.35% | 45.42% | 46.09% | 46.42% | 22.47% |
Interest Coverage | 2.80x | 2.92x | 2.73x | 2.39x | -0.13x | 0.28x | 1.14x | 2.11x | 2.40x | - |
Book Value / Share | 32.48 | 18.21 | 18.54 | 16.45 | 15.43 | 13.23 | 12.04 | 11.61 | 11.55 | 10.89 |
Revenue Growth | 55.7% | 53.68% | 7.18% | -10.42% | -4.85% | 9.7% | 3.63% | 8.61% | 10.15% | 12.89% |
Related:SBRA Dividend History·SBRA Revenue History·SBRA Price History·SBRA P/E History·SBRA Financial Ratios·SBRA Institutional Holders
SBRA SEC Filings & Documents
Sabra Health Care REIT, Inc. (SBRA) SEC filings — annual & quarterly reports (10-K, 10-Q)
SBRA Frequently Asked Questions
Sabra Health Care REIT, Inc. (SBRA) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Sabra Health Care REIT, Inc. (SBRA) reported $812.8M in revenue for fiscal year 2025. This represents a 9137% increase from $8.8M in 2010.
Sabra Health Care REIT, Inc. (SBRA) grew revenue by 10.2% over the past year. This is steady growth.
Yes, Sabra Health Care REIT, Inc. (SBRA) is profitable, generating $156.2M in net income for fiscal year 2025 (20.1% net margin).
Dividend & Returns
Yes, Sabra Health Care REIT, Inc. (SBRA) pays a dividend with a yield of 6.53%. This makes it attractive for income-focused investors.
Sabra Health Care REIT, Inc. (SBRA) has a return on equity (ROE) of 5.6%. This is below average, suggesting room for improvement.
Industry Metrics
Sabra Health Care REIT, Inc. (SBRA) generated Funds From Operations (FFO) of $352.8M in the trailing twelve months. FFO is the primary profitability metric for REITs.
Sabra Health Care REIT, Inc. (SBRA) offers a 6.53% dividend yield, which is attractive for income investors. REITs are required to distribute at least 90% of taxable income to shareholders.